Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + Marcaine versus fentanyl + Marcaine in femoral neck fracture surgery
IRCT20230805059046N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of dexmedetomidine, fentanyl and bupivacaine in pain (3 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoint: Amount and intensity of pain. Started Aug 2023; status: completed.
02
Drugs
dexmedetomidinefentanylbupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on IRCT20230805059046N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230805059046N1.